92
Views
16
CrossRef citations to date
0
Altmetric
Research Article

VIROSOMES IN VACCINE DEVELOPMENT: INDUCTION OF CYTOTOXIC T LYMPHOCYTE ACTIVITY WITH VIROSOME-ENCAPSULATED PROTEIN ANTIGENS

, , , , &
Pages 155-163 | Published online: 15 Jul 2002

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Selma Calcagnile & Gian Vincenzo Zuccotti. (2010) The virosomal adjuvanted influenza vaccine. Expert Opinion on Biological Therapy 10:2, pages 191-200.
Read now
R Handa, S Teo & R Booy. (2004) Influenza: current evidence and informed predictions. Expert Review of Vaccines 3:4, pages 443-451.
Read now
Reinhard Glück, Christian Moser & Ian C Metcalfe. (2004) Influenza virosomes as an efficient system for adjuvanted vaccine delivery. Expert Opinion on Biological Therapy 4:7, pages 1139-1145.
Read now

Articles from other publishers (13)

Toon Stegmann, Anna-Sophia Wiekmeijer, Kitty Kwappenberg, Suzanne van Duikeren, Farien Bhoelan, Denzel Bemelman, Thomas J. M. Beenakker, Willem-Jan Krebber, Ramon Arens & Cornelis J. M. Melief. (2023) Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides. Cancer Immunology, Immunotherapy 72:8, pages 2851-2864.
Crossref
Laura Fernández, Jose Carlos Solana, Carmen Sánchez, Mª Ángeles Jiménez, Jose M. Requena, Rhea Coler, Steven G. Reed, Jesus G. Valenzuela, Shaden Kamhawi, Fabiano Oliveira, Epifanio Fichera, Reinhard Glueck, Maria Elena Bottazzi, Gaurav Gupta, Pedro Cecilio, Begoña Pérez-Cabezas, Anabela Cordeiro-da-Silva, Luigi Gradoni, Eugenia Carrillo & Javier Moreno. (2021) Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant. Microorganisms 9:11, pages 2253.
Crossref
Rajeev Sharma, Nishi Mody, Surbhi Dubey, Udita Agrawal & Suresh Vyas. 2016. Handbook of Polyester Drug Delivery Systems. Handbook of Polyester Drug Delivery Systems 479 519 .
E. F. Borba, C. G. S. Saad, S. G. Pasoto, A. L. G. Calich, N. E. Aikawa, A. C. M. Ribeiro, J. C. B. Moraes, E. P. Leon, L. P. Costa, L. K. N. Guedes, C. A. A. Silva, C. R. Goncalves, R. Fuller, S. A. Oliveira, M. A. Ishida, A. R. Precioso & E. Bonfa. (2012) Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?. Rheumatology 51:6, pages 1061-1069.
Crossref
Mateusz Walczak, Arjan de Mare, Annelies Riezebos-Brilman, Joke Regts, Baukje-Nynke Hoogeboom, Jeroen T. Visser, Marc Fiedler, Pidder Jansen-Dürr, Ate G. J. van der Zee, Hans W. Nijman, Jan Wilschut & Toos Daemen. (2010) Heterologous Prime-Boost Immunizations with a Virosomal and an Alphavirus Replicon Vaccine. Molecular Pharmaceutics 8:1, pages 65-77.
Crossref
Janet E McElhaney. (2008) Influenza vaccination in the elderly: seeking new correlates of protection and improved vaccines. Aging Health 4:6, pages 603-613.
Crossref
Karin Tegerstedt, Andrea Franzén, Torbjörn Ramqvist & Tina Dalianis. (2007) Dendritic cells loaded with polyomavirus VP1/VP2Her2 virus-like particles efficiently prevent outgrowth of a Her2/neu expressing tumor. Cancer Immunology, Immunotherapy 56:9, pages 1335-1344.
Crossref
Norbert Suttorp, Tobias Welte & Reinhard MarrePablo D. Becker & Carlos A. Guzmán. 2007. Community-Acquired Pneumonia. Community-Acquired Pneumonia 201 245 .
Janet E McElhaneyKristin L Nichol. (2005) Influenza vaccines: crossing the translational gap to improve outcomes in the elderly. Aging Health 1:1, pages 167-177.
Crossref
Marc Brinkman, Juergen Walter, Swen Grein, Michael J. W. Thies, Torsten W. Schulz, Martin Herrmann, Christian O. A. Reiser & Juergen Hess. (2005) Beneficial therapeutic effects with different particulate structures of murine polyomavirus VP1-coat protein carrying self or non-self CD8 T cell epitopes against murine melanoma. Cancer Immunology, Immunotherapy 54:6, pages 611-622.
Crossref
Isabella Schöll, George Boltz-Nitulescu & Erika Jensen-Jarolim. (2005) Review of novel particulate antigen delivery systems with special focus on treatment of type I allergy. Journal of Controlled Release 104:1, pages 1-27.
Crossref
Ruth Schwaninger, Ernst Waelti, Paul Zajac, Antoinette Wetterwald, Dominique Mueller & Claude D. Gimmi. (2004) Virosomes as new carrier system for cancer vaccines. Cancer Immunology, Immunotherapy 53:11, pages 1005-1017.
Crossref
A.C.M Boon, S Plotkin, G.F Rimmelzwaan & A.D.M.E Osterhaus. (2004) Viral Vaccine meeting held in Barcelona, October 25–28, 2003. Vaccine 22:11-12, pages 1327-1334.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.